KR20000049667A - 과초산을 이용한 의료기기 세척제 및 그 제조방법 - Google Patents
과초산을 이용한 의료기기 세척제 및 그 제조방법 Download PDFInfo
- Publication number
- KR20000049667A KR20000049667A KR1020000021215A KR20000021215A KR20000049667A KR 20000049667 A KR20000049667 A KR 20000049667A KR 1020000021215 A KR1020000021215 A KR 1020000021215A KR 20000021215 A KR20000021215 A KR 20000021215A KR 20000049667 A KR20000049667 A KR 20000049667A
- Authority
- KR
- South Korea
- Prior art keywords
- peracetic acid
- hydrogen peroxide
- acid
- acetic acid
- present
- Prior art date
Links
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 title claims abstract description 88
- 238000004140 cleaning Methods 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 81
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 60
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 12
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000003381 stabilizer Substances 0.000 claims abstract description 6
- 230000032683 aging Effects 0.000 claims abstract description 4
- 239000012459 cleaning agent Substances 0.000 claims description 29
- 238000001223 reverse osmosis Methods 0.000 claims description 10
- 230000006641 stabilisation Effects 0.000 claims description 2
- 238000011105 stabilization Methods 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 36
- 230000001954 sterilising effect Effects 0.000 abstract description 21
- 238000003912 environmental pollution Methods 0.000 abstract description 7
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 15
- 230000000844 anti-bacterial effect Effects 0.000 description 14
- 239000000645 desinfectant Substances 0.000 description 14
- 238000000502 dialysis Methods 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 11
- 229910001220 stainless steel Inorganic materials 0.000 description 11
- 239000010935 stainless steel Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 230000001464 adherent effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 210000004215 spore Anatomy 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 description 8
- 238000007726 management method Methods 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000005708 Sodium hypochlorite Substances 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 206010073456 Microcolon Diseases 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000249 desinfective effect Effects 0.000 description 6
- 238000001631 haemodialysis Methods 0.000 description 6
- 230000000322 hemodialysis Effects 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000000385 dialysis solution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 208000003322 Coinfection Diseases 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 210000004666 bacterial spore Anatomy 0.000 description 3
- 230000007797 corrosion Effects 0.000 description 3
- 238000005260 corrosion Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 3
- 239000001095 magnesium carbonate Substances 0.000 description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012881 co-culture medium Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000000635 electron micrograph Methods 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 108010009004 proteose-peptone Proteins 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- AWNOGHRWORTNEI-UHFFFAOYSA-N 2-(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)ethyl acetate Chemical compound CC(=O)OCCC1=CCC2C(C)(C)C1C2 AWNOGHRWORTNEI-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 239000006159 Sabouraud's agar Substances 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- JLPULHDHAOZNQI-JLOPVYAASA-N [(2r)-3-hexadecanoyloxy-2-[(9e,12e)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC JLPULHDHAOZNQI-JLOPVYAASA-N 0.000 description 1
- GPFIZJURHXINSQ-UHFFFAOYSA-N acetic acid;nitric acid Chemical compound CC(O)=O.O[N+]([O-])=O GPFIZJURHXINSQ-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940054731 calcium acetate and magnesium carbonate Drugs 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 231100001224 moderate toxicity Toxicity 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000004686 pentahydrates Chemical class 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000012449 sabouraud dextrose agar Substances 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D11/00—Special methods for preparing compositions containing mixtures of detergents ; Methods for using cleaning compositions
- C11D11/04—Special methods for preparing compositions containing mixtures of detergents ; Methods for using cleaning compositions by chemical means, e.g. by sulfonating in the presence of other compounding ingredients followed by neutralising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/02—Inorganic compounds
- C11D7/04—Water-soluble compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/265—Carboxylic acids or salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/36—Organic compounds containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/50—Solvents
-
- C11D2111/20—
Abstract
Description
산도(pH) | 밀도 | 어는점 | |
헤모크린 | 0.8∼0.9 | 1.08 | -10℃(동결 용해 후 사용가능) |
균주 |
A : (Escherichia coli ) ATCC 2592B : (Salmonella typhimurium ) ATCC 14028C : (Staphylococcus aureus) ATCC 6538D : (Klebsiella pneumoniae ) ATCC 10051E : (Candida albicans ) ATTC 10251F : (Proteus mirabilis ) ATCC 21100G : (Bacillus subtilis ) KTCC 1021H :(Pseudomonas aeruginosa ) ATCC 9027I :(Bacillus cereus ) wildJ : (Bacillus cereus ) wildK : (Staphylococcus aureus ) ATCC 10051L : (Bacillus subtilis ) ATCC 9027 |
배지 | Nutrient broth |
Nutrient agar | |
Casein- peptone soymeal - peptone broth | |
Casein - peptone soymeal - peptone agar | |
Sabouraud broth | |
Sabouraud agar |
재질 | 3% | 5% |
알루미늄 99.5 | 0.00 g/100㎖ | 0.00 g/100㎖ |
스텐인레스 스틸 | 0.00 g/100㎖ | 0.00 g/100㎖ |
주석 | 0.00 g/100㎖ | 0.00 g/100㎖ |
아연철판 | 0.00 g/100㎖ | 0.00 g/100㎖ |
피브이씨(PVC) | 0.00 g/100㎖ | 0.00 g/100㎖ |
피피(PP) | 0.00 g/100㎖ | 0.00 g/100㎖ |
피이(PE) | 0.00 g/100㎖ | 0.00 g/100㎖ |
실리콘 | 0.00 g/100㎖ | 0.00 g/100㎖ |
폴리우레탄 | 0.00 g/100㎖ | 0.00 g/100㎖ |
합성수지 | 0.00 g/100㎖ | 0.00 g/100㎖ |
엘-튜브(L-tube) | 0.00 g/100㎖ | 0.00 g/100㎖ |
오링(O-ring) | 0.00 g/100㎖ | 0.00 g/100㎖ |
스프링(spring) | 0.00 g/100㎖ | 0.00 g/100㎖ |
파이프 | 0.00 g/100㎖ | 0.00 g/100㎖ |
연결튜브 | 0.00 g/100㎖ | 0.00 g/100㎖ |
니플(nipple) | 0.00 g/100㎖ | 0.00 g/100㎖ |
원액 | 10배 희석 | 35배 희석 |
2.95g/100㎖ | 1.06g/100㎖ | 0.46g/100㎖ |
초산이온 | 질산이온 | 인산이온 | 황산이온 | |
헤모크린 | 검출안됨 | 2.825(ppm) | 검출안됨 | 3.670(ppm) |
Claims (2)
- 과초산 0.01∼10%, 초산 5∼20%, 과산화수소 2~6%, 인산 1∼20%, 안정제인 1,1-디포스포닉 5∼1%, 역삼투압수 86.99~53.00%로 혼합된 것을 특징으로 하는 과초산을 이용한 의료기기 세척제.
- 역삼투압수 79~24%, 초산 10~30%를 교반기에 투입하여 일정시간 동안 고르게 혼합하는 단계와,과산화수소 5~25%를 투입하여 고르게 혼합하여 과초산을 형성하는 단계,상기 과정에서 생성된 과초산의 안정화와 제품의 산도(pH) 조절을 위해 인산1∼20%를 투입하여 고르게 혼합하는 단계와,전체적인 제품의 안정화 및 세척효능을 향상시키기 위해 안정제인 1,1-디포스포닉 5∼1%투입하여 고르게 혼합하는 단계와,상기 혼합물을 35~45℃ 온도에서 4~7시간 동안 보온시켜 과산화수소와 초산의 반응을 촉진시키는 단계와,상기 단계 후 상온에서 3일간 숙성시켜 과산화수소의 함량을 6% 미만으로 낮추는 단계로 제조되는 것을 특징으로 하는 과초산을 이용한 의료기기 세척제 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000021215A KR100363896B1 (ko) | 2000-04-21 | 2000-04-21 | 과초산을 이용한 의료기기 세척제 및 그 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000021215A KR100363896B1 (ko) | 2000-04-21 | 2000-04-21 | 과초산을 이용한 의료기기 세척제 및 그 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000049667A true KR20000049667A (ko) | 2000-08-05 |
KR100363896B1 KR100363896B1 (ko) | 2002-12-16 |
Family
ID=19666087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000021215A KR100363896B1 (ko) | 2000-04-21 | 2000-04-21 | 과초산을 이용한 의료기기 세척제 및 그 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100363896B1 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100515929B1 (ko) * | 2002-08-28 | 2005-09-20 | 이진식 | 양쪽 말단에 알콜성 기를 갖는 계면활성제를 함유한 의료기기 소독 세척제 및 그의 제조방법 2 |
KR100515928B1 (ko) * | 2002-08-28 | 2005-09-20 | 이진식 | 양쪽 말단에 알콜성 기를 갖는 계면활성제를 함유한 의료기기 소독 세척제 및 그의 제조방법 1 |
KR100876684B1 (ko) * | 2007-10-31 | 2009-01-07 | 이진식 | 과초산 및 아세틸살리실산을 함유하는 산성의 살균 조성물의 제조방법 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102307392B1 (ko) | 2019-12-30 | 2021-10-05 | (주)에이치피앤씨 | 안정성이 향상된 의료기기용 과초산 소독제 조성물 |
KR20220075633A (ko) | 2020-11-30 | 2022-06-08 | 주식회사 에이치피앤씨 | 보존안정성이 우수한 2액형 살균소독제 조성물 |
KR102520527B1 (ko) | 2020-12-24 | 2023-04-11 | 군산대학교산학협력단 | 안정성이 향상된 저농도 과초산계 소독제조성물 |
KR102573619B1 (ko) | 2021-01-14 | 2023-09-04 | (주)에이치피앤씨 | 보존안정성이 우수한 살균소독제 조성물 |
KR102610645B1 (ko) | 2021-10-22 | 2023-12-06 | 주식회사 퍼슨 | 단일제로 제공되는 과아세트산 용액의 신속 제조방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2639233B1 (fr) * | 1988-11-23 | 1994-05-06 | Air Liquide | Agent d'hygiene en hemodialyse |
AU661862B2 (en) * | 1991-07-15 | 1995-08-10 | Minntech Corporation | Stable, anticorrosive peracetic/peroxide sterilant |
GB9122048D0 (en) * | 1991-10-17 | 1991-11-27 | Interox Chemicals Ltd | Compositions and uses thereof |
JP3758417B2 (ja) * | 1998-06-02 | 2006-03-22 | ニプロ株式会社 | 透析装置の洗浄方法 |
-
2000
- 2000-04-21 KR KR1020000021215A patent/KR100363896B1/ko active IP Right Review Request
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100515929B1 (ko) * | 2002-08-28 | 2005-09-20 | 이진식 | 양쪽 말단에 알콜성 기를 갖는 계면활성제를 함유한 의료기기 소독 세척제 및 그의 제조방법 2 |
KR100515928B1 (ko) * | 2002-08-28 | 2005-09-20 | 이진식 | 양쪽 말단에 알콜성 기를 갖는 계면활성제를 함유한 의료기기 소독 세척제 및 그의 제조방법 1 |
KR100876684B1 (ko) * | 2007-10-31 | 2009-01-07 | 이진식 | 과초산 및 아세틸살리실산을 함유하는 산성의 살균 조성물의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR100363896B1 (ko) | 2002-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6762160B2 (en) | Composition for removing biofilms comprising a detergent and a salt forming acid | |
KR100317577B1 (ko) | 조성물과이의용도 | |
RU2127607C1 (ru) | Стабильный антикоррозионный состав для обработки медицинского инструментария и способ его получения | |
Babb et al. | Sporicidal activity of glutaraldehydes and hypochlorites and other factors influencing their selection for the treatment of medical equipment | |
KR100597092B1 (ko) | 과초산 수용액 및 그 제조방법 | |
JP3219698B2 (ja) | 殺菌消毒液の製造方法 | |
WO1997018707A1 (en) | Method for reprocessing medical devices utilizing a room temperature sterilant | |
KR100363896B1 (ko) | 과초산을 이용한 의료기기 세척제 및 그 제조방법 | |
US20070179193A1 (en) | Method for preparing aqueous composition for sterilization | |
Coates | An evaluation of the use of chlorine dioxide (Tristel One-Shot) in an automated washer/disinfector (Medivator) fitted with a chlorine dioxide generator for decontamination of flexible endoscopes | |
US7666354B2 (en) | Composition for sterilization comprising ω-alkoxyperoxycarboxylic acid | |
CN108157358A (zh) | 一种消毒液及其制备方法 | |
KR102208456B1 (ko) | 과채류 세척용 항균제 조성물 | |
Rushdy et al. | Bactericidal efficacy of some commercial disinfectants on biofilm on stainless steel surfaces of food equipment | |
Coates et al. | Sporicidal activity of mixtures of alcohol and hypochlorite. | |
US6331514B1 (en) | Sterilizing and disinfecting compound | |
JP2005211644A (ja) | 二酸化塩素を主成分とする新規殺菌剤組成によるウエットワイパーの除菌・殺菌 | |
KR102307392B1 (ko) | 안정성이 향상된 의료기기용 과초산 소독제 조성물 | |
US20150296800A1 (en) | Method for eliminating biofilms for cleaning medical instruments, in particular for combating nosocomial infections | |
JP2007051111A (ja) | 消毒又は滅菌用の組成物 | |
JP4963055B2 (ja) | 殺菌剤組成物 | |
KR101032872B1 (ko) | 컬럼형 반응기 및 코일관형 숙성반응기를 사용한 과초산용액의 제조방법 | |
CN113197199A (zh) | 一种器械消毒液及其制备方法和应用 | |
RU2815980C1 (ru) | Способ повышения эффективности дезинфектантов и состав комбинированных дезинфектантов против биоплёнок бактерий | |
Candeliere et al. | Biocidal and sporicidal efficacy of Pathoster® 0.35% and Pathoster® 0.50% against bacterial agents in potential bioterrorism use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121126 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20131125 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20141124 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20151125 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20161125 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20171127 Year of fee payment: 16 |
|
J202 | Request for trial for correction [limitation] | ||
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2018105000050; TRIAL DECISION FOR CORRECTION REQUESTED 20180516 Effective date: 20180626 |
|
J203 | Request for trial for invalidation of correction [invalidation of limitation] |
Free format text: TRIAL NUMBER: 2018100002169; TRIAL FOR INVALIDATION OF CORRECTION FOR INVALIDATION OF CORRECTION |
|
FPAY | Annual fee payment |
Payment date: 20181120 Year of fee payment: 17 |
|
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2018100002169; TRIAL DECISION FOR INVALIDATION OF CORRECTION REQUESTED 20180712 Effective date: 20181221 Free format text: TRIAL NUMBER: 2018100002167; TRIAL DECISION FOR INVALIDATION REQUESTED 20180712 Effective date: 20181221 |
|
J121 | Written withdrawal of request for trial | ||
J122 | Written withdrawal of action (patent court) | ||
J122 | Written withdrawal of action (patent court) |